Richard Shippy

Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation.

Octave Health Group, Inc. provides therapy services. It offers coaching and classes and group sessions related to anxiety, depression, chronic insomnia, bipolar disorder, trauma, chronic pain, personality perfectionism, anger management, relationships, intimacy, work stress, parenthood, and related general issues. The company was founded by Kristen Scarlett, Sarah Gundle, and Sandeep Acharya and is headquartered in New York, NY.

Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA.

Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA.

Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.

The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry.

Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022.

Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ.

Genometrix, Inc. performs commercial physical and biological research. The private company is based in The Woodlands, TX.

Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California.

Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

GenoLogics Life Sciences Software, Inc. provides laboratory information management system software. Its products include tools for genomics, proteomics, biorepositories, and laboratories. The firm’s product, Clarity LIMS, is used for clinical and research labs that provide next generation sequencing and genomics services. Its services encompass customer support, technical, project and implementation management, and training. The company was founded by Jonathan Kerr and James Degreef in 2002 and is headquartered in Victoria, Canada.

American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021.

Armature-FAD doo engages in the provision of engineering and consultancy services. The company was founded on June 12, 1970 and is headquartered in Belgrade, Serbia.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO.

SEMATECH, Inc. provides research and development services in semiconductor manufacturing technology. It offers research in design, lithography, interconnect, and other facets of chip manufacturing. The company was established in 1986 and is headquartered in Austin, TX.

The Coriell Institute for Medical Research provides research support services to enhance biobanking and distribution initiatives. The private company is based in Camden, NJ. The company offers expert assistance, resources, and solutions to accelerate scientific research goals. The company provides laboratory services such as stem cell R & D, custom lab services, kitting, organoids, iPSC reprogramming, and genomic and epigenomic services.

LetsGetChecked, Inc. operates online platform which connects customers and diagnostic laboratories. It offers its diagnostics services for general health, sexual health, cancer screening and fertility and hormone check. The company was founded by Peter Foley in 2014 and is headquartered in Dun Laoghaire, Ireland.

Part of Roche Holding AG, Clinical Micro Sensors, Inc. is a private company that manufactures instruments used in genetic diagnostics testing. The company is based in Pasadena, CA. The company was founded by Jon Faiz Kayyem. Clinical Micro Sensors was acquired by Osmetech Ltd. from Motorola, Inc. on August 10, 2005 for $2.45 million.

Part of Thermo Fisher Scientific, Inc., True Materials, Inc. develops semiconductor technologies for life science applications. The private company is based in San Francisco, CA. True Materials was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on August 08, 2008 for $25 million.